Connacht Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Connacht Asset Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$246K	Buy
2023 Q1	$223K	Sell
2022 Q4	$323K	Buy
2022 Q3	$222K	Sell
2022 Q2	$227K	Buy
2022 Q1	$273K	Sell
2021 Q4	$947K	Buy